2022 At the Biozentrum a lot of talented and curiosity-driven women are doing impactful research – here we have featured two postdocs and PhD candidates as well as research group leader. Laura de Smalen, PhD Student, Group…
Samplequeuer Samplequeuer is a web-based solution to submit, schedule and track samples and their associated data sets, developed by Research IT. The software is used by the Biozentrum's Proteomics Core Facility . The…
CV of Prof. Dr. Flavio Donato ORCID 0000-0002-0732-1654 Nationality : Italian Positions: Since 2019 Assistant Professor of Neurobiology, Biozentrum of the University of Basel, Basel, Switzerland. 2013 – 2019 Postdoctoral…
Where to find information on (image) data management General Research Data Management (RDM) information: Clickable overview to all different aspects of RDM: rdmkit.elixir-europe.org Recommended Metadata for Biological…
SEAL Technology The innovative gene therapy approach (called SEAL technology), developed by Prof. Markus Rüegg and Prof. Peter Yurchenco and their teams over the past 20 years, overcomes the lack of laminin-α2 in muscle…
CV of Prof. Dr. Jean Pieters ORCID 0000-0002-5284-9757 Nationality: Dutch Positions: Since 2002 Professor of Biochemistry, Biozentrum, University of Basel, Switzerland 2000 – 2002 Permanent Member, Basel Institute for…
How do cells control gene dosage alterations during evolution and disease? Sexually reproducing animals contain two genome copies - one from each parent. Deviations from this twofold dosage can lead to diseases such as…
The coronin pathway and cell population size control T cells require the protein coronin 1 to reach and maintain their cell population size. The movie illustrates T cells dividing until their appropriate density has been…
SEAL Therapeutics AG: Gene therapy for muscular dystrophy The Biozentrum spin-off develops an innovative gene therapy to treat congenital muscular dystrophy. Cross-section through treated LAMA2 MD muscle with individual…
This website uses cookies to collect data from users and improve functionality. By continuing to browse the site you are agreeing to this. Receive more information by reading our privacy policy.
